Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
101 hedge funds and large institutions have $114M invested in Avid Bioservices, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 34 increasing their positions, 12 reducing their positions, and 10 closing their positions.
200% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 10
183% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 12
138% more capital invested
Capital invested by funds: $48M → $114M (+$66.4M)
25% more funds holding
Funds holding: 81 → 101 (+20)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
31% less call options, than puts
Call options by funds: $418K | Put options by funds: $604K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Snyder Capital Management
San Francisco,
California
|
+$11.2M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$5.23M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$3.8M |
| 4 |
BlackRock
New York
|
+$1.87M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$2.71M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$1.08M |
| 3 |
BP
Bandera Partners
New York
|
-$1.05M |
| 4 |
SIC
Schwartz Investment Counsel
Plymouth,
Michigan
|
-$682K |
| 5 |
EP
Eversept Partners
New York
|
-$394K |
CDMO Hedge Fund Activity: Q3 2018 in Review
101 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2018, worth a combined $114M — up 138% from $48M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new CDMO positions and 10 closed out — a net gain of 20 holders — while 34 added to existing stakes and 12 trimmed.
The largest buyer was Snyder Capital Management, opening a new position worth an estimated $11.2M. The largest seller was Kennedy Capital Management, exiting entirely with an estimated $2.71M sold.
- 101 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2018, up from 81 in Q2 2018.
- Funds reported $114M of Avid Bioservices, Inc. Common Stock stock for Q3 2018, up 138% quarter-over-quarter.
- 30 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2018 and 10 closed out, a net change of +20 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2018 was Snyder Capital Management, an estimated $11.2M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q3 2018 was Kennedy Capital Management, an estimated $2.71M sold.
Based on aggregated 13F filings for Q3 2018.